Treace Medical Concepts Inc (TMCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 42,195 | 49,769 | 33,055 | 29,967 | 29,047 |
| Cost of Goods | 8,039 | 9,021 | 6,090 | 5,291 | 5,130 |
| Gross Profit | 34,156 | 40,748 | 26,965 | 24,676 | 23,917 |
| Operating Expenses | 47,971 | 44,266 | 38,373 | 36,900 | 32,143 |
| Operating Income | -13,776 | -3,497 | -11,318 | -11,933 | -8,096 |
| Interest Expense | 1,285 | 1,311 | 1,190 | 946 | 951 |
| Other Income | 1,607 | 396 | 375 | -4,355 | 11 |
| Pre-tax Income | -13,454 | -4,412 | -12,133 | -17,234 | -9,036 |
| Net Income Continuous | -13,454 | -4,412 | -12,133 | -17,234 | -9,036 |
| Net Income | $-13,454 | $-4,412 | $-12,133 | $-17,234 | $-9,036 |
| EPS Basic Total Ops | -0.23 | -0.08 | -0.22 | -0.31 | -0.16 |
| EPS Basic Continuous Ops | -0.23 | -0.08 | -0.22 | -0.31 | -0.16 |
| EPS Diluted Total Ops | -0.23 | -0.08 | -0.22 | -0.31 | -0.16 |
| EPS Diluted Continuous Ops | -0.23 | -0.08 | -0.22 | -0.31 | -0.16 |
| EBITDA(a) | $-13,075 | $-2,631 | $-10,785 | $-11,460 | $-7,717 |